Stay updated with breaking news from Sci Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- SFP Holding, Inc. (Summit Companies), a leading fire and life safety service and installation company, announced that the company's...
PROVIDENCE, R.I., June 10, 2021 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. ("Ocean") today announced that it has publicly filed a Registration Statement on Form S-1 (the "Registration Statement") with
CymaBay Therapeutics Inc. (CBAY) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. CymaBay Therapeutics Inc. (NASDAQ: CBAY) Q1 2021 Earnings Call Good day, ladies and gentlemen, and welcome to CymaBay's first-quarter 2021 financial results and business update conference call. [Operator instructions] Please be advised that this call will be recorded at the company's request. It is also being webcast live on the Investor section of CymaBay's website at www.cymabay.com. Now I would like to turn the call over t...
Nano-X Imaging Ltd. (NNOX) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Nano-X Imaging Ltd. (NASDAQ: NNOX) Q1 2021 Earnings Call Glenn Garmont -- Investor Relations Thank you, Joe, and thanks to everybody for joining the Nano-X Imaging first-quarter 2021 conference call. On today's call, we will hear from Ran Poliakine, chairman of the board of directors and chief executive officer; and Itzhak Maayan, chief financial officer. Before we begin, I'd like to remind everyone that management's remarks today...
Search jobs 07-May-2021 Science 37 to Become Publicly Listed via Merger with LifeSci Acquisition II Corp., Powering the Clinical Trial Operating System of the Future Transaction values Science 37 at an enterprise value of approximately $1.05 billion at closing Positions Science 37 with a balance sheet of up to $250 million to fund its decentralized trial technology platform, extend into new adjacencies, and power the next generation in clinical research $80 million via LifeSci Acquisition II Corp., a special purpose acquisition company with no publ...